Editor's Choice – Sex Differences in Response to Administration of Heparin During Non-Cardiac Arterial Procedures

Abstract

Females are more prone to complications during non-cardiac arterial procedures (NCAPs) than males. The current study investigated the difference in the effect of peri-procedural prophylactic heparin in males and females, using the activated clotting time (ACT). This was a retrospective analysis of a prospective multicentre cohort study. All patients undergoing elective NCAP using heparin and ACT measurements between January 2016 and March 2020 were included. Two heparin dosage protocols were used: weight based dosing of 100 IU/kg (international units per kilogram) or a bolus of 5 000 IU. The primary outcome was the anticoagulatory effect of heparin after five minutes, measured by ACT. Secondary outcomes were the effect of heparin after 30 minutes, bleeding complications, and arterial thromboembolic complications (ATECs). A total of 778 patients were included; 26% were female. After 100 IU/kg (n= 300), females more often reached longer ACT (< 200 seconds: 22% vs. 25%, p= .62; 200 - 250 seconds: 41% vs. 53%, p= .058; 251 - 280 seconds, 26% vs. 15%, p= .030). The mean ACT after 100 IU/kg heparin was 233 seconds (95% confidence interval [CI] 224 - 243) for females and 226 seconds (95% CI 221 - 231) for males (p= .057). After a bolus of 5 000 IU of heparin (n= 411), females reached significantly higher levels of anticoagulation than males (mean ACT 204 seconds vs. 190 seconds: p ≤ .001; ACT < 200 seconds: 44% vs. 66%; p < .001; ACT 200 - 250 seconds: 47% vs. 30%, p= .001; ACT 251 - 280 seconds: 7.8% vs. 2.3%, p= .009). Thirty minutes after heparin administration, 58% of all patients had an ACT < 200 seconds. ATECs did not differ between females and males (6.9% vs. 5.1%, p= .33) but bleeding complications were higher in females (27% vs. 16%, p= .001). Heparin leads to significantly longer ACT in females during NCAP. Further research is needed to investigate whether individually based heparin protocols lead to fewer bleeding complications and lower incidence of ATECs.